1. Home
  2. Analysis
  3. Mavyret
  4. Blood-glucose-decreased

Mavyret and Blood glucose decreased - a phase IV clinical study of FDA data

Summary:

Blood glucose decreased is reported as a side effect among people who take Mavyret (glecaprevir; pibrentasvir), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Metformin, and have Hepatitis c.

The phase IV clinical study analyzes which people have Blood glucose decreased when taking Mavyret. It is created by eHealthMe based on reports of 10,526 people who have side effects when taking Mavyret from the FDA, and is updated regularly.

What is Mavyret?

Mavyret has active ingredients of glecaprevir; pibrentasvir. eHealthMe is studying from 10,533 Mavyret users. Check the latest studies of Mavyret.

What is Blood glucose decreased?

Blood glucose decreased is found to be associated with 1,341 drugs and 1,376 conditions by eHealthMe. Check the latest studies of Blood glucose decreased.

On Jul, 15, 2026

10,526 people reported to have side effects when taking Mavyret.
Among them, 12 people (0.11%) have Blood glucose decreased.

Could Mavyret cause Blood glucose decreased?

Among these 12 people:

How long have people been on Mavyret when they have Blood glucose decreased? *

  • < 1 month: 50 %
  • 1 - 6 months: 50 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

What is the gender of people who have Blood glucose decreased when taking Mavyret? *

  • female: 58.33 %
  • male: 41.67 %

What is the age of people who have Blood glucose decreased when taking Mavyret? *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 16.67 %
  • 30-39: 16.67 %
  • 40-49: 0.0 %
  • 50-59: 16.67 %
  • 60+: 50.0 %

What are other drugs people take besides Mavyret? *

  1. Metformin: 3 people, 25.00%
  2. Soma: 2 people, 16.67%
  3. Buprenorphine Hydrochloride: 2 people, 16.67%
  4. Gabapentin: 2 people, 16.67%
  5. Insulin: 2 people, 16.67%
  6. Zoloft: 1 person, 8.33%
  7. Hydroxyzine: 1 person, 8.33%
  8. Basaglar: 1 person, 8.33%
  9. Benadryl: 1 person, 8.33%
  10. Calcium: 1 person, 8.33%

What are other side effects people have besides Blood glucose decreased? *

  1. Headache (pain in head): 2 people, 16.67%
  2. Fatigue (feeling of tiredness): 2 people, 16.67%
  3. Fall: 2 people, 16.67%
  4. Abdominal Discomfort: 2 people, 16.67%
  5. Seizures (abnormal excessive or synchronous neuronal activity in the brain): 2 people, 16.67%
  6. Malaise (a feeling of general discomfort or uneasiness): 1 person, 8.33%
  7. Lower Limb Fracture: 1 person, 8.33%
  8. Hospitalisation: 1 person, 8.33%
  9. Hip Fracture: 1 person, 8.33%
  10. High Blood Pressure: 1 person, 8.33%

What are the existing conditions these people have? *

  1. Hepatitis C: 4 people, 33.33%
  2. Diabetes: 3 people, 25.00%
  3. Renal Disorder (kidney disease): 1 person, 8.33%
  4. Hepatitis B: 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Mavyret and have Blood glucose decreased?

- Check whether Blood glucose decreased is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Mavyret:

Blood glucose decreased treatments and more:

How severe was Blood glucose decreased and when was it recovered:

Expand to all the drugs that have ingredients of glecaprevir; pibrentasvir:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Mavyret:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Blood glucose decreased:

Browse all the conditions that are associated with Blood glucose decreased:

How the study uses the data?

The study uses data from the FDA. It is based on glecaprevir; pibrentasvir (the active ingredients of Mavyret) and Mavyret (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.